Automated intake captures accurate patient messages, streamlines clinical tasks, and helps practices regain valuable staff ...

Senior professionals in the life sciences must approach networking with strategic intention; not simply exchanging business ...

The best rhinoplasty in Seattle is by Dr. Sajan SEATTLE, WA / ACCESS Newswire / November 20, 2025 / In Seattle's growing ...

Together, the organizations will strengthen revenue cycle operations as Sauk Prairie Healthcare leverages Jorie AI's intelligent automation framework. PRAIRIE DU SAC, WISCONSIN / ACCESS Newswire / ...

Acquisition Will Enhance ClearPoint Neuro's Commercial Scale, Drive Operational Leverage, and Support Its Long-Term Strategy in CNS Drug Delivery Innovation SOLANA BEACH, CALIFORNIA / ACCESS Newswire ...

November 2025 - Poolbeg Pharma (AIM: POLB, 'Poolbeg' or the 'Company'), a clinical-stage biopharmaceutical company with a core focus on transforming the cancer immunotherapy field, announces that the ...

First-of-its-kind AI-powered chronic care management platform moves clinically proven tools outside the doctor's office ARLINGTON, VA / ACCESS Newswire / November 20, 2025 / FriskaAi, an innovative ...

CEO's personal open-market investment reflects long-term alignment with shareholders and continued commitment to transparency, excellence and innovation. MESA, ARIZONA / ACCESS Newswire / November 20, ...

KENNESAW, GA / ACCESS Newswire / November 20, 2025 / When many people hear the term artificial intelligence, their guard goes up, questions are raised about confidentiality, integrity, and a ...

Announces three-year business strategy and commercial growth drivers, targeting up to 10% revenue growth in 2026Expects to expand seasonal vaccine franchise from three to up to six approved products ...

Crofelemer can potentially extend lives of MVID patients - infants and children who face the lethal natural history of the diseaseParenteral support reduction of up to 37% is groundbreaking; No ...

SAN DIEGO, CA / ACCESS Newswire / November 20, 2025 / Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or "Revelation"), a clinical-stage life sciences company that is focused on rebalancing ...